t-2 toxin has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramu, A; Ramu, N; Yagen, B | 1 |
| Daigle, KW; Ehrlich, KC | 1 |
2 other study(ies) available for t-2 toxin and Experimental Leukemia
| Article | Year |
|---|---|
The cytotoxicity of T-2 toxin and related 12,13-epoxytrichothecenes to Adriamycin-sensitive and -resistant P388 leukemia cells.
Topics: Animals; Antineoplastic Agents; Cell Division; Chemical Phenomena; Chemistry; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Esterification; Hydroxylation; Leukemia P388; Leukemia, Experimental; Mice; Sesquiterpenes; Solubility; Structure-Activity Relationship; T-2 Toxin; Trichothecenes; Tumor Cells, Cultured; Verapamil; Water | 1989 |
Protein synthesis by mammalian cells treated with C-3-modified analogs of the 12,13-epoxytrichothecenes T-2 and T-2 tetraol.
Topics: Animals; Cell Line; Chlorocebus aethiops; Kidney; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Polyribosomes; Protein Biosynthesis; Sesquiterpenes; Structure-Activity Relationship; T-2 Toxin | 1985 |